Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the ...

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after surgery ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

Pharmaceuticals for the development of a potential. “We are pleased to partner with Amylyx to advance GLP-1 receptor antagonism research. This collaboration and development agreement is an example of ...

Amylyx Pharmaceuticals Inc ( (AMLX) ) has provided an update.

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...

Novo Nordisk (NVO) released mixed clinical-trial results for its potential Ozempic successor on Friday, leaving Wall Street disappointed.

An array of pharmaceutical pills with the company's logo on the bottle. Cramer noted that Eli Lilly ... reportedly on an idea that RFK Jr. is not a fan of GLP-1 weight loss drugs like Lilly's Mounjaro ...

Potential entry into high growth GLP-1 market valued at nearly $50 billion in 2024 and projected to surpass $100 billion by 2029 BALTIMORE, December 19, 2024--(BUSINESS WIRE)--TNF Pharmaceuticals ...